These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 22156927)

  • 21. Mass spectrometry based metabolomic approaches in urinary biomarker study of women's cancers.
    Woo HM; Kim KM; Choi MH; Jung BH; Lee J; Kong G; Nam SJ; Kim S; Bai SW; Chung BC
    Clin Chim Acta; 2009 Feb; 400(1-2):63-9. PubMed ID: 19010317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabonomics of human colorectal cancer: new approaches for early diagnosis and biomarker discovery.
    Ni Y; Xie G; Jia W
    J Proteome Res; 2014 Sep; 13(9):3857-70. PubMed ID: 25105552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genomic medicine in non-small cell lung cancer: paving the path to personalized care.
    Sriram KB; Larsen JE; Yang IA; Bowman RV; Fong KM
    Respirology; 2011 Feb; 16(2):257-63. PubMed ID: 21044232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fast sampling for quantitative microbial metabolomics.
    van Gulik WM
    Curr Opin Biotechnol; 2010 Feb; 21(1):27-34. PubMed ID: 20149631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolomics in urogenital cancer.
    Bujak R; Daghir E; Rybka J; Koslinski P; Markuszewski MJ
    Bioanalysis; 2011 Apr; 3(8):913-23. PubMed ID: 21510764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emerging field of metabolomics: big promise for cancer biomarker identification and drug discovery.
    Patel S; Ahmed S
    J Pharm Biomed Anal; 2015 Mar; 107():63-74. PubMed ID: 25569286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oncometabolomics in cancer research.
    Gupta S; Chawla K
    Expert Rev Proteomics; 2013 Aug; 10(4):325-36. PubMed ID: 23992416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Challenges and developments in tandem mass spectrometry based clinical metabolomics.
    Ceglarek U; Leichtle A; Brügel M; Kortz L; Brauer R; Bresler K; Thiery J; Fiedler GM
    Mol Cell Endocrinol; 2009 Mar; 301(1-2):266-71. PubMed ID: 19007853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical proteomics in breast cancer: a review.
    Gast MC; Schellens JH; Beijnen JH
    Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liquid chromatography-mass spectrometry based global metabolite profiling: a review.
    Theodoridis GA; Gika HG; Want EJ; Wilson ID
    Anal Chim Acta; 2012 Jan; 711():7-16. PubMed ID: 22152789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular profiling of cancer--the future of personalized cancer medicine: a primer on cancer biology and the tools necessary to bring molecular testing to the clinic.
    Stricker T; Catenacci DV; Seiwert TY
    Semin Oncol; 2011 Apr; 38(2):173-85. PubMed ID: 21421108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
    Vogelzang NJ; Benowitz SI; Adams S; Aghajanian C; Chang SM; Dreyer ZE; Janne PA; Ko AH; Masters GA; Odenike O; Patel JD; Roth BJ; Samlowski WE; Seidman AD; Tap WD; Temel JS; Von Roenn JH; Kris MG
    J Clin Oncol; 2012 Jan; 30(1):88-109. PubMed ID: 22147736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting long-term survival and treatment response in breast cancer patients receiving neoadjuvant chemotherapy by MR metabolic profiling.
    Cao MD; Sitter B; Bathen TF; Bofin A; Lønning PE; Lundgren S; Gribbestad IS
    NMR Biomed; 2012 Feb; 25(2):369-78. PubMed ID: 21823183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unveiling cellular biochemical reactions via metabolomics-driven approaches.
    Saito N; Ohashi Y; Soga T; Tomita M
    Curr Opin Microbiol; 2010 Jun; 13(3):358-62. PubMed ID: 20430690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A systems approach to model metastatic progression.
    Taylor BS; Varambally S; Chinnaiyan AM
    Cancer Res; 2006 Jun; 66(11):5537-9. PubMed ID: 16740685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Future perspectives of personalized oncology.
    Stambuk S; Sundov D; Kuret S; Beljan R; Andelinović S
    Coll Antropol; 2010 Jun; 34(2):763-9. PubMed ID: 20698168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The emergent role of metabolic phenotyping in dynamic patient stratification.
    Lindon JC; Nicholson JK
    Expert Opin Drug Metab Toxicol; 2014 Jul; 10(7):915-9. PubMed ID: 24905565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolomics: the "new clinical chemistry" for personalized neonatal medicine.
    Antonucci R; Atzori L; Barberini L; Fanos V
    Minerva Pediatr; 2010 Jun; 62(3 Suppl 1):145-8. PubMed ID: 21089734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nutritional modulation of the metabonome: applications of metabolic phenotyping in translational nutritional research.
    Kinross J; Li JV; Muirhead LJ; Nicholson J
    Curr Opin Gastroenterol; 2014 Mar; 30(2):196-207. PubMed ID: 24468802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel methodologies in metabolic profiling with a focus on molecular diagnostic applications.
    Hyötyläinen T
    Expert Rev Mol Diagn; 2012 Jun; 12(5):527-38. PubMed ID: 22702368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.